Illinois Tool Works (ITW) posted net profit margins of 21.3%, up from 19.2% a year ago, while delivering earnings growth of 9.7% this year, above its 5-year average growth rate of 9.1% annually. Forecasts call for future earnings growth of…
Category: 6. Business
-

Patient Expectations in Allergic Rhinitis Treatment: AMixed-Methods St
Introduction
Allergic rhinitis (AR) is a seasonal or perennial inflammatory condition of the nasal mucosa that not only affects breathing, but also the quality of life of those who experience it. Its prevalence has increased in recent decades.1,
Continue Reading
-

RIP tipping? Customers complain they spend $150 a year on ‘unnecessary’ tips as gratuities get out of control.
By Charles Passy
A new survey points to a growing tipping backlash as 65% of Americans say they’re fed up with doling out those dollars
The tip screen has become a fact of life at many businesses – and customers aren’t crazy…
Continue Reading
-

Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
- Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented
- Biomarker data informing use of investigational CAR-T cell therapy rapcabtagene autoleucel (YTB323) in systemic lupus…
Continue Reading
-

BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
- Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across measures of…
Continue Reading
-

The Role of Ferroptosis-Related Gene CRYAB in Asthma: Insights from Bi
Introduction
Asthma is a heterogeneous respiratory disease, generally classified into Type 2 (T2) and non-Type 2 (non-T2) subtypes, characterized by chest tightness, cough, wheezing, and shortness of breath, affecting approximately 1–18% of the…
Continue Reading
-

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
Elinzanetant (Lynkuet; Bayer) just became the
most recent nonhormonal treatment approved for moderate to severe vasomotor symptoms (VMS) associated withmenopause .1 AtThe Menopause Society 2025 Annual Meeting , findings from multiple…Continue Reading
-

VIRAGE Trial at ESMO 2025: Oncolytic Adenovirus VCN-01 Plus Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Cancer
At the ESMO Congress 2025 in Berlin, Dr. Rocio Garcia-Carbonero (Madrid, Spain) presented the findings of the VIRAGE trial (2216MO) — a randomized phase IIb, open-label study evaluating the oncolytic adenovirus VCN-01 combined…
Continue Reading
-
Electricity prices are climbing, but not for the reason you think – The Washington Post
- Electricity prices are climbing, but not for the reason you think The Washington Post
- It’s the power lines, stupid Politico
- Residential electricity prices surge ahead of C&I rates: Berkeley Lab Utility Dive
- E&E News: Why Trump and Democrats are…
Continue Reading

